tiprankstipranks
Advertisement

DBEU - ETF AI Analysis

Compare

Top Page

DBEU

Xtrackers MSCI Europe Hedged Equity ETF (DBEU)

Rating:64Neutral
Price Target:
DBEU, the Xtrackers MSCI Europe Hedged Equity ETF, has a solid overall rating driven by high-quality European leaders like ASML, AstraZeneca, HSBC, and Novartis, which all show strong financial performance and generally positive outlooks. Stable blue chips such as Nestlé, Siemens, and Shell further support the fund, though some holdings face valuation concerns, mixed technical signals, or growth challenges that slightly weigh on the rating. The main risk factor is the fund’s concentration in European markets, meaning its performance is closely tied to the economic and market conditions in Europe.
Positive Factors
Strong Recent Performance
The ETF has shown solid gains over the year so far and in recent months, indicating positive momentum in its underlying European stocks.
Geographic Diversification Across Europe
Holdings spread across major European markets like the UK, France, Germany, and Switzerland help reduce the impact of weakness in any single country.
Leading Growth and Financial Names in Top Holdings
Several top positions, including a major semiconductor company and large banks, have delivered strong or steady results, supporting the fund’s overall performance.
Negative Factors
Moderate Expense Ratio
The fund’s fee is not especially low for a broad equity ETF, which slightly reduces the net return investors keep over time.
Mixed Performance Among Top Holdings
A few key positions, including a large software company and some consumer and healthcare names, have shown weak or negative performance, which can drag on returns.
Limited Sector Clarity and Low Tech Exposure
A large portion of assets is grouped into a broad 'General' category and the fund has relatively small exposure to technology, which may limit participation in some growth trends.

DBEU vs. SPDR S&P 500 ETF (SPY)

DBEU Summary

DBEU is an ETF that follows the MSCI Europe U.S. Dollar Hedged Index, giving you broad exposure to large and mid-sized companies across many European countries while trying to reduce the impact of currency swings between the euro and the U.S. dollar. It holds well-known names like Nestlé and Shell, and covers many sectors, which can help diversify a U.S.-focused portfolio and tap into Europe’s long-term growth. A key risk is that European stock prices can still rise or fall significantly with the market, even if currency movements are partly smoothed out.
How much will it cost me?The Xtrackers MSCI Europe Hedged Equity ETF (DBEU) has an expense ratio of 0.45%, meaning you’ll pay $4.50 per year for every $1,000 invested. This is slightly higher than average for passively managed ETFs because it includes a currency hedging strategy to reduce the impact of exchange rate fluctuations.
What would affect this ETF?The DBEU ETF could benefit from positive economic growth in Europe, particularly in sectors like financials and industrials, which make up a significant portion of its holdings. Additionally, its currency hedging strategy provides protection against euro-to-dollar fluctuations, which can stabilize returns for U.S. investors. However, potential risks include economic slowdowns in Europe, regulatory changes affecting key industries, or geopolitical tensions that could impact the performance of its top holdings like ASML and Nestlé.

DBEU Top 10 Holdings

DBEU’s story is all about Europe’s heavy hitters, with a tilt toward health care, banks, and a few industrial and tech standouts. ASML has been a key engine for returns this year, while HSBC and Banco Santander add fuel as rising financials. In health care, AstraZeneca is quietly pulling its weight, but Roche and Novartis have been more mixed, sometimes tapping the brakes. Siemens is rebounding, yet SAP has been dragging the fund lately. Overall, it’s a developed Europe play, not a global one, with no single stock dominating the wheel.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV3.89%$29.39M€477.33B106.32%
76
Outperform
HSBC Holdings2.16%$16.32M£226.99B58.35%
80
Outperform
AstraZeneca2.07%$15.61M$292.69B32.74%
80
Outperform
Roche Holding AG2.02%$15.28M$327.04B22.13%
73
Outperform
Novartis AG1.95%$14.70MCHF207.57B22.14%
80
Outperform
Nestlé SA1.86%$14.04MCHF205.30B-1.29%
71
Outperform
Shell (UK)1.77%$13.37M£184.86B32.32%
73
Outperform
Siemens1.58%$11.94M€185.31B21.53%
74
Outperform
SAP SE1.29%$9.71M€171.96B-40.47%
66
Neutral
TotalEnergies SE1.26%$9.51M€164.70B45.23%
78
Outperform

DBEU Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
49.81
Negative
100DMA
49.35
Positive
200DMA
47.35
Positive
Market Momentum
MACD
0.25
Positive
RSI
46.16
Neutral
STOCH
7.66
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DBEU, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 50.46, equal to the 50-day MA of 49.81, and equal to the 200-day MA of 47.35, indicating a neutral trend. The MACD of 0.25 indicates Positive momentum. The RSI at 46.16 is Neutral, neither overbought nor oversold. The STOCH value of 7.66 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for DBEU.

DBEU Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$745.62M0.45%
64
Neutral
$30.12B0.06%
62
Neutral
$9.43B0.50%
63
Neutral
$722.09M0.07%
63
Neutral
$115.02M0.09%
64
Neutral
$114.67M0.25%
63
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DBEU
Xtrackers MSCI Europe Hedged Equity ETF
49.72
7.98
19.12%
VGK
Vanguard FTSE Europe ETF
EZU
iShares MSCI Eurozone ETF
SPEU
SPDR Portfolio Europe ETF
FLEE
Franklin FTSE Europe ETF
GSEU
Goldman Sachs ActiveBeta Europe Equity ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement